About
Technology
Issues
FAQ
Links
Official Page
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.